Valerie Malyvanh Jansen - 19 Oct 2021 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Chief Medical Officer
Signature
/s/ Joseph Ferra, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
19 Oct 2021
Net transactions value
$0
Form type
4
Filing time
21 Oct 2021, 18:32:15 UTC
Next filing
16 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELEV Employee Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 19 Oct 2021 Common Stock 40,000 $7.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on October 19, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.